Legal Compliance
Research peptides sit in a legally nuanced position. Most synthetic peptides are not controlled substances under the Misuse of Drugs Act 1971, and they are not licensed medicinal products under the Human Medicines Regulations 2012. That does not place them outside regulation entirely. The MHRA oversees whether a substance is being marketed for medicinal purposes, and context determines everything.
Supplying peptides with therapeutic claims — or for human consumption — invites regulatory scrutiny. Legal status depends on intended use, how a compound is marketed, and who is buying it.
Under UK law, a substance becomes a medicinal product when it is presented as treating, preventing, or diagnosing a condition in humans or animals — or when it functions as one. Premio Peptides does not present any compound in this way. Our products are supplied as research chemicals for laboratory and academic use only. No therapeutic claims are made, and none of our compounds are MHRA-licensed medicines.
Researchers should know that the MHRA can investigate suppliers where compounds are marketed or used in ways that imply medicinal intent. Premio Peptides operates with that line clearly in view.
Every compound Premio Peptides sells is designated for in vitro research, laboratory analysis, and scientific study only. Not for human or veterinary consumption. Not for clinical use or self-administration. This classification carries legal and ethical weight — it is not a disclaimer inserted for form’s sake.
Research-use-only compounds can be purchased legally in the UK for legitimate scientific purposes, provided they are handled in appropriate settings by qualified individuals and in line with institutional guidelines. Use outside that scope falls beyond the intended purpose of our products and beyond our responsibility as a supplier.
Placing an order with Premio Peptides constitutes confirmation that the compounds will be used solely for lawful research purposes. Buyers are responsible for understanding the legal framework that applies to their institution, jurisdiction, and intended use.
Researchers based at universities, private laboratories, or commercial R&D operations should consult their institution’s compliance or ethics team before ordering. Importation rules may apply if you are ordering from outside Great Britain. Premio Peptides does not provide legal advice. Nothing on this website should be read as guidance on the legality of any specific research application.
Premio Peptides operates on a clear standard: stock held in the UK, dispatched from UK-based facilities, and a third-party certificate of analysis (CoA) supplied with every product. CoAs are produced by independent laboratories and confirm compound identity and purity.
We do not make MHRA approval claims. We do not market products for human use. We do not supply buyers who cannot confirm a legitimate research purpose. Product listings and marketing language are reviewed on an ongoing basis to ensure they remain within appropriate limits. Transparency about what we are — and what we are not — is the most defensible position a supplier can hold.
To place an order, buyers must confirm at checkout that they are purchasing for research purposes only, that they are 18 or older, and that they understand the research-use-only designation of all compounds. We reserve the right to decline orders where there is reasonable doubt about stated research intent.
Orders placed by 2pm on working days are dispatched the same day from UK stock. Every shipment includes the relevant certificate of analysis. We do not dispatch to jurisdictions where importation or possession of the relevant compound is prohibited.
Most synthetic peptides are not controlled substances under UK law and are not classified as licensed medicines, provided they are not marketed or used for medicinal purposes. Legal status depends heavily on context — specifically, intended use and how a compound is represented at point of sale. Buyers are responsible for satisfying themselves on the legality of any specific compound in their jurisdiction.
No. Premio Peptides does not hold MHRA approval, and our products are not licensed medicinal products. MHRA approval applies to medicines intended for human or veterinary use. Our compounds are supplied exclusively for research purposes and are not presented as medicines. We make no claims to the contrary.
Our products are intended for researchers, scientists, and academics conducting legitimate laboratory or scientific research. Buyers should be affiliated with or operating within a suitable research context — a university, private laboratory, or commercial R&D organisation. We cannot supply individuals who are unable to confirm a lawful research purpose.
A certificate of analysis (CoA) is a document produced by an independent third-party laboratory confirming the identity and purity of a compound. Every Premio Peptides product ships with one. It allows researchers to verify exactly what they have received — a standard requirement in legitimate research settings and a basic condition for accurate record-keeping and reproducibility.
No. None of our compounds are approved for clinical trials, human administration, or veterinary application. Any such use falls entirely outside the intended purpose of our products and is the sole responsibility of the individual or organisation involved. Compounds destined for clinical use require separate regulatory authorisation that our products do not carry.
Consult your institution's legal, ethics, or compliance team before placing an order. Independent legal advice may also be appropriate. Premio Peptides cannot advise on the legal status of compounds for individual use cases, and nothing on this site constitutes legal guidance.
All orders placed by 2pm are dispatched same day from UK-based stock. Every compound ships with a third-party certificate of analysis. Order for research use only.